
Dissolution Testing is used by the Pharmaceutical industry to characterize the dissolution properties of the active drug itself and the active drug release and dissolution from a dosage form. Dissolution Testing is used to formulate the drug dosage form and to develop Quality Control specifications for its manufacturing process. In-Vitro Dissolution is therefore a critical test that has to correlate with in-vivo studies. Dissolution Testing is described in EP, USP chapters and FDA guidelines.

Created, as a spin-off, by the leader in Dissolution Testing instrumentation, SPS Pharma Services brings to the pioneers in Flow-Through Cell Dissolution technology, or Apparatus 4, or USP 4, a new dissolution tool to help its several pharma customers testing novel drug formulations and developing new R&D automation tools. SPS Pharma Services, as an independant expert company, works on every Compendial Dissolution Method, USP 1 to 7, including the analytical technique development : UV, HPLC, UVFO and more.

SPS Pharma Services is the unique CRO : Contract Research Organization dedicated to Dissolution Testing and what is daily linked to it in R&D departments: solubility, formulation, controlled release, IVIVC, novel dosage forms, in-vivo GI dissolution, particle size distribution, polymorphism, Intrinsic Dissolution, Apparent Dissolution...
SPS Pharma Services brings to the Dissolution Testing Outsourcing market another essential source of expertise and know-how based on long term experienced analysts and specialized worldwide level external consultants: system and method feasibility studies, method development, transfer to automation, development of methods and instruments for formulations including APIs : Active Pharmaceutical Ingredients, MR/ER tablets, medical devices as drug-eluting stents, microspheres, injectables, implants and many more.
During development, dissolution time is precious.